Catheter-Related Bloodstream Infection Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Catheter-Related Bloodstream Infection Market Size Shifted, And What Is the Outlook Through 2034?
Over the past few years, the market size for catheter-related bloodstream infections has significantly expanded. It is projected to increase from a value of $1.53 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. Various factors have contributed to its historical growth. These include increased instances of chronic illnesses, heightened awareness and education, a rise in hospital-acquired infections, a growing aging population, and heightened infection management plans within hospital and healthcare environments.
How Much Will the Catheter-Related Bloodstream Infection Market Be Worth in 2029?
The market size for catheter-related bloodstream infections is predicted to witness a marked growth spike in the coming years. It is projected to reach $2.05 billion in 2029, with a compound annual growth rate (CAGR) of 6.0%. The growth in the projected period can be ascribed to a rise in healthcare-related infections (hais), increasing recognition and training, improved infection control practice programs, the expansion of the healthcare infrastructure, a surge in the senior citizen population, and supportive government policies and initiatives. Notable trends for the forecast period include advancements in biomaterial, the evolution of smart catheter technology, the creation of more efficient catheter lock solutions featuring advanced antimicrobial attributes, advancements in catheter sterilization processes, and the development of automated flushing systems.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp
Which is the Largest Company in the Catheter-Related Bloodstream Infection Market?
Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC
What Are the Main Market Drivers in the Catheter-Related Bloodstream Infection Industry?
The escalating occurrence of infections contracted within healthcare facilities is projected to fuel the expansion of the catheter-related bloodstream infection market. Patients often contract Hospital-acquired infections (HAIs) while receiving medical treatment for other ailments, typically starting to appear 48 hours or more post-admission. The rise in these types of infections is due to a variety of causes, including resistant microorganisms, ineffective infection control protocols, and patient vulnerability. The contribution of catheter-related bloodstream infections to hospital-acquired infections is significant due to their invasive characteristics and likelihood of microbial colonization, placing those patients with indwelling catheters at risk. For example, the National Library of Medicine, a biomedical library based in the US, recorded an international healthcare-associated infection (HAI) rate of 0.14% in January 2023, which increases annually by 0.06%. Therefore, the escalating prevalence of infections gained in hospitals will act as a catalyst for the catheter-related bloodstream infection market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp
How Is the Catheter-Related Bloodstream Infection Market Segments Structured?
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents
What Strategic Trends Are Transforming the Catheter-Related Bloodstream Infection Market?
Prominent businesses in the catheter-related bloodstream infection market are pioneering new catheter lock solutions to amplify infection prevention and enhance patient outcomes. Catheter lock solutions, which are liquids that are instilled into a catheter to avert infections and preserve catheter patency during periods of non-use, are being created. To illustrate, CorMedix Inc., an American biopharmaceutical corporation specializing in product development and commercialization, was granted approval by the US Food and Drug Administration in November 2023 for their catheter lock solution known as DefenCath (taurolidine and heparin). This solution, intended for adult patients with kidney failure who require chronic hemodialysis via a central venous catheter (CVC), is an antimicrobial and antifungal solution designed to minimize catheter-related bloodstream infections (CRBSIs). It effectively mingling heparin for anticoagulation with the comprehensive antimicrobial attributes of taurolidine.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Catheter-Related Bloodstream Infection Market?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16646
This Report Delivers Insight On:
1. How big is the catheter-related bloodstream infection market, and how is it changing globally?
2. Who are the major companies in the catheter-related bloodstream infection market, and how are they performing?
3. What are the key opportunities and risks in the catheter-related bloodstream infection market right now?
4. Which products or customer segments are growing the most in the catheter-related bloodstream infection market?
5. What factors are helping or slowing down the growth of the catheter-related bloodstream infection market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
